The Department Of Justice Approves $69 Billion CVS-Aetna Merger With Part D Divestiture

The Department of Justice (DOJ) recently approved a $69 billion merger between CVS and Aetna. As part of the approval, Aetna agreed to sell off its Medicare Part D business.

Medicare Part D—also known as the Medicare prescription drug benefit—is an optioned federal government program that helps Medicare beneficiaries pay for self-administered prescription drugs through insurance premiums. Aetna’s Part D business was sold to WellCare at a price of $2.2 million. According to antitrust regulators, the divestiture absolves the DOJ’s competitive concerns over a merger of such magnitude.

CVS Health Corporation is an American . . .